Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1992. Start Trial.
Date Value
December 31, 2025 520.75M
December 31, 2024 439.12M
December 31, 2023 401.35M
December 31, 2022 21.04M
December 31, 2021 101.72M
December 31, 2020 82.84M
December 31, 2019 72.08M
December 31, 2018 99.28M
December 31, 2017 19.19M
December 31, 2016 -67.23M
December 31, 2015 -40.36M
December 31, 2014 11.14M
December 31, 2013 92.22M
March 31, 2013
March 31, 2012 -2.482M
March 31, 2011 -28.44M
March 31, 2010 -12.25M
March 31, 2009 34.59M
Date Value
March 31, 2008 42.42M
March 31, 2007 83.73M
March 31, 2006 116.53M
March 31, 2005 -74.26M
March 31, 2004 -98.25M
March 31, 2003 -48.75M
March 31, 2002 -42.68M
March 31, 2001 -17.99M
March 31, 2000 -33.03M
March 31, 1999 -14.25M
March 31, 1998 -1.137M
March 31, 1997 -17.18M
March 31, 1996 -5.547M
March 31, 1995 -9.056M
March 31, 1994 -12.29M
March 31, 1993 -5.973M
March 31, 1992 -45.22M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Amarin Corp. Plc 6.744M
Jazz Pharmaceuticals Plc 1.356B
Prothena Corp. Plc -163.58M
ACADIA Pharmaceuticals, Inc. 109.84M
Biogen, Inc. 2.205B